Joseph Taleb

195 posts

Joseph Taleb banner
Joseph Taleb

Joseph Taleb

@Joseph_Taleb

San Diego, California เข้าร่วม Eylül 2017
482 กำลังติดตาม266 ผู้ติดตาม
ทวีตที่ปักหมุด
Joseph Taleb รีทวีตแล้ว
Sam Tsimikas, MD
Sam Tsimikas, MD@Lpa_Doc·
We have another advance today to translate @OxPL_apoB to research studies. Please see the CLIA validation of OxPL-apoB and OxPL-apo(a) jlr.org/article/S0022-… These assays will be useful in understanding results of the phase 3 Lp(a) trials and will complement @BostonHeartDX for clinical use. We hope to have OxPL-apo(a) also available for patient use in 2026.
Sam Tsimikas, MD tweet mediaSam Tsimikas, MD tweet media
English
1
6
38
9.7K
Joseph Taleb
Joseph Taleb@Joseph_Taleb·
There’s beauty in seeing a path meet its destination. Some carry a depth shaped by origin and effort - you’re one of them. Even in uneven soil, some flowers find the light. Onward, with pride in all you’ve earned. @StavrosDrakos @CPKyriakopoulos @kon_sideris
Christos P. Kyriakopoulos@CPKyriakopoulos

June will be bittersweet after 7 incredible years at @UofUInternalMed @UofUCV @NEH_CVRTI, but elated to join @DukeCardFellows @DukeHeartCenter @DCRINews ! Grateful for my family, mentors, & friends, & especially @StavrosDrakos & @CarolineMilneMD. Excited for the journey ahead !

English
1
2
5
584
Joseph Taleb รีทวีตแล้ว
Journal of Cardiac Failure
PROs provide valuable insight into pts health status, but can they be used to improve risk prediction in HF? 💡In this study, adding PROs to risk models improved ability to predict adverse events. How does your HF program utilize PRO assessments? 🔗 bit.ly/3FjX9j6
Journal of Cardiac Failure tweet media
English
0
7
14
1.5K
Joseph Taleb รีทวีตแล้ว
John Power
John Power@JohnPowerMD·
At last—our analysis predicting severe outcomes in ICI-myocarditis is out. With just ECG, LVEF, troponin, and clinical history, you can estimate risk at initial presentation. Grateful for the incredible mentorship @CardioOncology @DrJESalem .. true world-class investigators!
Javid Moslehi@CardioOncology

Excited to report this important collaboration which we hope helps us understand ICI-myocarditis better, published in #EHJ today! Along with the great @DrJESalem! @ehj_ed @JBauersachsMD #CardioOnc @UCSFCardiology @UCSFCancer academic.oup.com/eurheartj/adva…

English
0
3
29
5.7K
Joseph Taleb
Joseph Taleb@Joseph_Taleb·
Congrats @CPKyriakopoulos and team! In this cohort of CS patients transferred from spoke to hub 🏥, we identified 🔑 factors, both inherent and management-related, linked to better outcomes. Insights to help guide escalation of care! @UCSDCardFellows @UCSDCardiology
Christos P. Kyriakopoulos@CPKyriakopoulos

Excited to share our publication @JAHA_AHA studying spoke-to-hub #CS transfers ! Shorter stay & transfer from ⬇️ level of care spoke, ⬇️ VIS at admission to the hub & shorter time to tMCS assoc w/ ⬆️ rates of NHS @UofUHealth @UofUCV @UofUInternalMed ahajournals.org/doi/full/10.11…

English
0
2
3
545
Joseph Taleb รีทวีตแล้ว
Stavros George Drakos
Stavros George Drakos@StavrosDrakos·
Want to attend #UCARS25 to enjoy the terrific bench-to-bedside agenda but can’t make the trip to scenic SLC, Utah? Join live with our Complimentary Live Feed Broadcast - Register Now: tristalong9.wixsite.com/ucarslivefeed2… Agenda, Feb 20 & 21, 2025: medicine.utah.edu/internal-medic…
Stavros George Drakos@StavrosDrakos

1/ #UCARS25 Abstract Deadline Jan 12 : medicine.utah.edu/internal-medic… Terrific Agenda: opportunity to interact with leading experts: @HowardARockman @KiranKhush1 @RobGersztenMD @PilarAlcaidePhD @SmarxLab @JasonKatzMD @LiviuKlein @NirUrielMD @Netuka_ivan @manreetkanwar @stevenhsu_md

Salt Lake City, UT 🇺🇸 English
0
19
34
3K
Joseph Taleb รีทวีตแล้ว
Joseph Taleb รีทวีตแล้ว
Sam Tsimikas, MD
Sam Tsimikas, MD@Lpa_Doc·
Breaking news for the lipid community: the FDA has approved Ionis’ medicine – the first and only treatment for adults with FCS in the U.S. as an adjunct to diet. Proud to be part of a determined, dedicated team. Read more: ir.ionis.com/news-releases/…
Sam Tsimikas, MD tweet media
English
8
24
100
6.1K